$MDBH
MDB Capital Holdings LLC Stock $mdbh

$mdbh Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000149315224012008 Filed on March 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$974.1K	$6.045M	$1.219M
YoY Change	-12.67%	395.91%	-112.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$7.041M	$13.97M	$6.973M
YoY Change	258.7%	100.34%	23.64%
% of Gross Profit
Research & Development	$461.1K	$528.2K	$348.1K
YoY Change	781.44%	51.74%	-22.65%
% of Gross Profit
Depreciation & Amortization	$58.97K	$196.9K	$147.8K
YoY Change	36.69%	33.29%	195.5%
% of Gross Profit
Operating Expenses	$7.502M	$14.50M	$7.321M
YoY Change	272.27%	98.03%	20.22%
Operating Profit		$5.995M	$1.219M
YoY Change		391.81%
Interest Expense	$370.9K		$227.3K
YoY Change	63.2%
% of Operating Profit			18.64%
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.207M	-$7.584M	-$5.875M
YoY Change	822.98%	29.08%	-62.51%
Income Tax	-$256.2K	$127.9K	$0.00
% Of Pretax Income
Net Earnings	-$5.549M	-$6.969M	-$5.314M
YoY Change	946.77%	31.14%	-64.81%
Net Earnings / Revenue	-569.72%	-115.28%	-435.95%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.60	-$0.86	-$0.57
COMMON SHARES
Basic Shares Outstanding	4.296M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.358M	$7.358M	$4.953M
YoY Change	48.56%	48.56%	-20.5%
Cash & Equivalents	$6.110M	$6.110M	$4.953M
Short-Term Investments
Other Short-Term Assets	$523.8K	$523.8K	$309.8K
YoY Change	69.06%	69.06%	106.55%
Inventory
Prepaid Expenses
Receivables	$882.3K	$882.3K	$809.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.764M	$8.764M	$6.072M
YoY Change	44.33%	44.33%	-11.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$866.5K	$3.187M	$2.034M
YoY Change	38.72%	56.64%	56.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$30.89M	$30.89M	$17.27M
YoY Change	78.85%	78.85%	15601.36%
Other Assets	$144.6K	$144.6K	$323.2K
YoY Change	-55.25%	-55.25%
Total Long-Term Assets	$3.187M	$34.22M	$19.63M
YoY Change	56.64%	74.34%	1302.08%
TOTAL ASSETS
Total Short-Term Assets	$8.764M	$8.764M	$6.072M
Total Long-Term Assets	$3.187M	$34.22M	$19.63M
Total Assets	$42.99M	$42.99M	$25.70M
YoY Change	67.25%	67.25%	211.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$578.2K	$578.2K	$698.8K
YoY Change	-17.25%	-17.25%	20.48%
Accrued Expenses	$3.521M	$3.521M	$1.678M
YoY Change	109.8%	109.8%	123.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.524M	$5.524M	$2.377M
YoY Change	132.41%	132.41%	78.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$140.7K	$140.7K	$215.0K
YoY Change	-34.56%	-34.56%	34.38%
Total Long-Term Liabilities	$140.7K	$140.7K	$215.0K
YoY Change	-34.56%	-34.56%	34.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.524M	$5.524M	$2.377M
Total Long-Term Liabilities	$140.7K	$140.7K	$215.0K
Total Liabilities	$5.665M	$5.672M	$3.061M
YoY Change	118.56%	85.33%	52.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.09M
YoY Change	136.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.31M	$37.31M	$22.64M
YoY Change
Total Liabilities & Shareholders Equity	$42.99M	$42.99M	$25.70M
YoY Change	67.25%	67.25%	211.53%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$5.549M	-$6.969M	-$5.314M
YoY Change	946.77%	31.14%	-64.81%
Depreciation, Depletion And Amortization	$58.97K	$196.9K	$147.8K
YoY Change	36.69%	33.29%	195.5%
Cash From Operating Activities	-$2.052M	-$7.161M	-$6.572M
YoY Change	25.34%	8.97%	12.72%
INVESTING ACTIVITIES
Capital Expenditures	$83.15K	$438.8K	$193.3K
YoY Change	169.7%	127.06%	-53.99%
Acquisitions
YoY Change
Other Investing Activities	-$16.88M	-$7.759M	-$16.19M
YoY Change	229.26%	-52.07%
Cash From Investing Activities	-$16.97M	-$8.198M	-$16.38M
YoY Change	228.9%	-49.96%	3800.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$25.29M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-69.30K	$17.76M	21.68M
YoY Change	-144.04%	-18.07%
NET CHANGE
Cash From Operating Activities	-2.052M	-$7.161M	-6.572M
Cash From Investing Activities	-16.97M	-$8.198M	-16.38M
Cash From Financing Activities	-69.30K	$17.76M	21.68M
Net Change In Cash	-19.09M	$2.405M	-1.273M
YoY Change	187.55%	-288.95%	-79.63%
FREE CASH FLOW
Cash From Operating Activities	-$2.052M	-$7.161M	-$6.572M
Capital Expenditures	$83.15K	$438.8K	$193.3K
Free Cash Flow	-$2.135M	-$7.600M	-$6.765M
YoY Change	28.01%	12.34%	8.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001934642
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation		usd
CY2022Q4	MDBH	Clearing Deposits Current ClearingDepositsCurrent		usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer		usd
CY2022Q4	MDBH	Deferred Costs Related To Deferred Revenue DeferredCostsRelatedToDeferredRevenue		usd
CY2022Q4	MDBH	Payables To Noncustomers PayablesToNoncustomers		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest		usd
CY2022	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills		usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2023	MDBH	Payments For Proceeds Purchases Of Investment Securities At Cost Less Impairment PaymentsForProceedsPurchasesOfInvestmentSecuritiesAtCostLessImpairment		usd
CY2022	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue		usd
CY2022	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal		usd
CY2022	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived		usd
CY2022	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities		usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2022	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	MDBH	Payments Of Initial Public Offering Costs PaymentsOfInitialPublicOfferingCosts		usd
CY2023	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution		usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	MDBH	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest		usd
CY2022	MDBH	Modification Of Lease Rightofuse Asset And Lease Liability ModificationOfLeaseRightofuseAssetAndLeaseLiability		usd
CY2022	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal		usd
CY2022	MDBH	Relienquishment Of Deferred Costs Of Initial Public Offering From Prior Year RelienquishmentOfDeferredCostsOfInitialPublicOfferingFromPriorYear		usd
CY2023	MDBH	Sales Of Warrants SalesOfWarrants		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	MDBH	Investment Securities At Cost Less Impairment Received In Lieu Of Cash Payment InvestmentSecuritiesAtCostLessImpairmentReceivedInLieuOfCashPayment		usd
CY2022	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Initial Public Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToInitialPublicOffering		usd
CY2023	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Private Placement Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToPrivatePlacementOffering		usd
CY2022Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations		usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer		usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration	http://fasb.org/us-gaap/2023#LeaseholdImprovementsMember
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2022	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased		usd
CY2023	us-gaap	Interest Expense InterestExpense		usd
CY2023	MDBH	Change In Fair Value Of Simply Agreement For Future Equity ChangeInFairValueOfSimplyAgreementForFutureEquity		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	0.0667	pure
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments		usd
CY2022Q4	MDBH	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability		usd
CY2023Q4	MDBH	Deferred Tax Assets Intercompany Warrants DeferredTaxAssetsIntercompanyWarrants		usd
CY2022Q4	MDBH	Deferred Tax Assets Warrants DeferredTaxAssetsWarrants		usd
CY2022Q4	MDBH	Deferred Tax Assets Bonus Expense DeferredTaxAssetsBonusExpense		usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2022Q4	MDBH	Deferred Tax Liabilities Investment Securities DeferredTaxLiabilitiesInvestmentSecurities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	323224	usd
CY2023Q4	MDBH	Deferred Costs Related To Deferred Revenue DeferredCostsRelatedToDeferredRevenue	75328	usd
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	RBSM, LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	Dallas, TX
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4952624	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2023Q4	MDBH	Unbilled Receivables UnbilledReceivables	695598	usd
CY2022Q4	MDBH	Unbilled Receivables UnbilledReceivables	783520	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2023Q4	MDBH	Clearing Deposits Current ClearingDepositsCurrent	260000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	309818	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2022Q4	MDBH	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2022Q4	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	69303	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624644	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1409732	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2022Q4	us-gaap	Assets Assets	25701071	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	578214	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	698782	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1105078	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	254745	usd
CY2023Q4	MDBH	Payables To Noncustomers PayablesToNoncustomers	1405293	usd
CY2023Q4	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	140703	usd
CY2022Q4	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	214998	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1423538	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5665177	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2592063	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49405779	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27764453	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12092927	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5124110	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37312852	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	22640343	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7250	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	468665	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42985279	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25701071	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1503649	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	15433	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
CY2023	us-gaap	Fee Income FeeIncome	4233120	usd
CY2022	us-gaap	Fee Income FeeIncome	1115001	usd
CY2023	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities	50000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	308250	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	88539	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	5995027	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1218966	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8627022	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2822693	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1123401	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1107313	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1695017	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1653760	usd
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	602393	usd
CY2022	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	348621	usd
CY2023	MDBH	Clearing And Other Charges ClearingAndOtherCharges	389963	usd
CY2022	MDBH	Clearing And Other Charges ClearingAndOtherCharges	16112	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1024697	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14498171	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7321281	usd
CY2023	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-8503144	usd
CY2022	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-6102315	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	919345	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	227249	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7583799	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5875066	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127918	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7711717	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5875066	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-742900	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-561013	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6968817	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5314053	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023	MDBH	Stock Issued During Period Value Of Initial Public Offering StockIssuedDuringPeriodValueOfInitialPublicOffering	17444659	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	65411	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4412741	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7711717	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6761337	usd
CY2022Q1	MDBH	Distribution Of Invizyne And Patent Vest To Members DistributionOfInvizyneAndPatentVestToMembers	-661799	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-209182	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5890356	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5890356	usd
	us-gaap	Temporary Equity Elimination As Partof Reorganization TemporaryEquityEliminationAsPartofReorganization	5890356	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6552155	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24946142	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	106940	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2723700	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	325000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	218355	usd
	us-gaap	Profit Loss ProfitLoss	-5665884	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7711717	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5875066	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1503649	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	15433	usd
CY2023	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	710584	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4412741	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	218355	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	196938	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	147750	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	81964	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	13806	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	75328	usd
CY2023	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	-38880	usd
CY2023	MDBH	Payments To Acquire Investment Securities At Fair Value Made By Our Licensed Broker Dealer PaymentsToAcquireInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer	1587500	usd
CY2022	MDBH	Payments To Acquire Investment Securities At Fair Value Made By Our Licensed Broker Dealer PaymentsToAcquireInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer	854108	usd
CY2022	MDBH	Payments For Proceeds Purchases Of Investment Securities At Cost Less Impairment PaymentsForProceedsPurchasesOfInvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2023	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	632851	usd
CY2023	MDBH	Proceeds From Warrants Issued As Part Of Investment Banking Deal ProceedsFromWarrantsIssuedAsPartOfInvestmentBankingDeal	165087	usd
CY2023	MDBH	Income Recognized From Warrants Received IncomeRecognizedFromWarrantsReceived	2645620	usd
CY2023	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities	50000	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	72787	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	341179	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	473970	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	67130	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-120786	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	122290	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	850333	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	224995	usd
CY2023	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers	-1405293	usd
CY2023	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-35415	usd
CY2022	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	53893	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7161037	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6571820	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	32455756	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	27073172	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	24696649	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	10884252	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	438784	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	193252	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8197891	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16382172	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	25289660	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19999992	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	436578	usd
CY2023	MDBH	Payments Of Initial Public Offering Costs PaymentsOfInitialPublicOfferingCosts	2166698	usd
CY2023	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	69303	usd
CY2022	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	323224	usd
CY2022	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	2723700	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	125000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17763991	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21681158	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2405063	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1272834	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6225458	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	9	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	127918	usd
CY2022	MDBH	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest	502930	usd
CY2023	MDBH	Record Rightofuse Asset And Operating Lease Liability RecordRightofuseAssetAndOperatingLeaseLiability	698249	usd
CY2022	MDBH	Record Rightofuse Asset And Operating Lease Liability RecordRightofuseAssetAndOperatingLeaseLiability	813003	usd
CY2023	MDBH	Warrants Received As Part Of Investment Banking Deal WarrantsReceivedAsPartOfInvestmentBankingDeal	2480533	usd
CY2022	MDBH	Sales Of Warrants SalesOfWarrants	27757	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	6049225	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	200000	usd
CY2023	MDBH	Investment Securities At Cost Less Impairment Received In Lieu Of Cash Payment InvestmentSecuritiesAtCostLessImpairmentReceivedInLieuOfCashPayment	100000	usd
CY2023	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Initial Public Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToInitialPublicOffering	65411	usd
CY2022	MDBH	Issuance Of Warrants To Purchase Class Stock Related To Private Placement Offering IssuanceOfWarrantsToPurchaseClassStockRelatedToPrivatePlacementOffering	106940	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4952624	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1247881	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zqdgRKSiIGC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zgmnMyUHS7v5">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the disclosure of contingent assets and liabilities. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in the valuation of investment securities, accruals for potential liabilities, valuing equity instruments issued for services, the estimate of the fair value of the lease liability and related right of use assets, and the realization of any deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	598714	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	MDBH	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2023Q4	us-gaap	Cash Cash	5511092	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	598714	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3943000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2000000	usd
CY2023Q4	us-gaap	Deposits Deposits	2000000	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1247881	usd
CY2023Q4	MDBH	Clearing Deposits Current ClearingDepositsCurrent	260000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2023	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	95000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	47380	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	325777	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	12131	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	309818	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	34103	usd
CY2022Q4	MDBH	Prepaid Derivative Assets Current PrepaidDerivativeAssetsCurrent	64395	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	61994	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	47932	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	57894	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2022Q4	MDBH	Investment Securities At Cost Less Impairment Broker Dealer InvestmentSecuritiesAtCostLessImpairmentBrokerDealer	50000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2022Q4	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1503649	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	15433	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	6031	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	24664642	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16188920	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	51645	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16137275	usd
CY2023	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities	50000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	2645620	usd
CY2023	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	652925	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	165087	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	832577	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1327809	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	889025	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461319	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	264381	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624644	usd
CY2023	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized	100000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	80000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2021Q4	us-gaap	Grants Receivable GrantsReceivable	468353	usd
CY2023	MDBH	Grant Costs Expensed GrantCostsExpensed	2836876	usd
CY2022	MDBH	Grant Costs Expensed GrantCostsExpensed	2312857	usd
CY2022	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased	72451	usd
CY2023	MDBH	Grant Fees GrantFees	117332	usd
CY2022	MDBH	Grant Fees GrantFees	79724	usd
CY2023	MDBH	Grant Funds Received GrantFundsReceived	-2881421	usd
CY2022	MDBH	Grant Funds Received GrantFundsReceived	-2123853	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2023	MDBH	Grant Costs Expensed GrantCostsExpensed	2836876	usd
CY2022	MDBH	Grant Costs Expensed GrantCostsExpensed	2312857	usd
CY2023	MDBH	Grant Drawdowns GrantDrawdowns	2954208	usd
CY2022	MDBH	Grant Drawdowns GrantDrawdowns	2465032	usd
CY2023	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	3482386	usd
CY2022	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	2660942	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	107925	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	259246	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3186609	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1503649	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8	usd
CY2023	us-gaap	Fee Income FeeIncome	4233120	usd
CY2023	MDBH	Impairment Of Investment Securities ImpairmentOfInvestmentSecurities	50000	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	308250	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	5995027	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8627022	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1123401	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1695017	usd
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	602393	usd
CY2023	MDBH	Clearing And Other Charges ClearingAndOtherCharges	389963	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1532197	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13969993	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	528178	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14498171	usd
CY2023	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-8503144	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	919345	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7583799	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127918	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7711717	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-742900	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6968817	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2034376	usd
CY2022Q4	us-gaap	Assets Assets	25701071	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	15433	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7	usd
CY2022	us-gaap	Fee Income FeeIncome	1115001	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	88539	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1218966	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2822693	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1107313	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1653760	usd
CY2022	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	348621	usd
CY2022	MDBH	Clearing And Other Charges ClearingAndOtherCharges	16112	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1024697	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6973196	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	348085	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7321281	usd
CY2022	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-6102315	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	227249	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5875066	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5875066	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5875066	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-561013	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5314053	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	1355070	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y29D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1018012	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.66
CY2023	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P6Y11M4D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2085359	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.43
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	409158	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y29D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	636478	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.43
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M7D
CY2022Q3	us-gaap	Advance Rent AdvanceRent	12556	usd
CY2022Q3	MDBH	Base Rent BaseRent	13937	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1123401	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1107313	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	1300
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1600	usd
CY2022Q3	us-gaap	Cash Available For Distributions CashAvailableForDistributions	2723700	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	697246	usd
CY2022	MDBH	Proceeds From Sale Of Investment Securities At Fair Value Made By Our Licensed Broker Dealer ProceedsFromSaleOfInvestmentSecuritiesAtFairValueMadeByOurLicensedBrokerDealer	632851	usd
CY2022	MDBH	Change In Fair Value ChangeInFairValue	64395	usd
CY2023Q4	srt	Net Capital NetCapital	7081449	usd
CY2022Q4	srt	Net Capital NetCapital	2836889	usd
CY2023Q4	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	3372465	usd
CY2023Q4	srt	Minimum Net Capital Required For Entity1 MinimumNetCapitalRequiredForEntity1	224831	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	380614	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	317966	usd
CY2023	MDBH	Payment For Licensed Products PaymentForLicensedProducts	250000	usd
CY2023	MDBH	Cumulative Net Sales CumulativeNetSales	1000000	usd
CY2023Q2	us-gaap	Advance Rent AdvanceRent	14371	usd
CY2023Q2	MDBH	Base Rent BaseRent	16747	usd
CY2023Q2	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.025	pure
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P60M
CY2023Q4	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend for 60 additional months.
CY2023Q4	us-gaap	Advance Rent AdvanceRent	13277	usd
CY2023Q4	MDBH	Base Rent BaseRent	15391	usd
CY2023Q4	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.030	pure
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P91M
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1409732	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1423538	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M29D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M29D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0740	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0653	pure
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	206837	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	147661	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1018002	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	813003	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	146836	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	123898	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	275589	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	37569	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	422425	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	161467	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	491624	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	503684	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	516001	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	528586	usd
CY2023Q4	MDBH	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	993274	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3033169	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	617280	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	105827	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	22091	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	127918	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6978436	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6978436	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	carried forward for 20 years
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0127	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0190	pure
CY2023	MDBH	Effective Income Tax Rate Reconciliation Income Loss Excluded From Nontaxable Entities EffectiveIncomeTaxRateReconciliationIncomeLossExcludedFromNontaxableEntities	-0.0181	pure
CY2022	MDBH	Effective Income Tax Rate Reconciliation Income Loss Excluded From Nontaxable Entities EffectiveIncomeTaxRateReconciliationIncomeLossExcludedFromNontaxableEntities	0.0090	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0017	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0000	pure
CY2023	MDBH	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.0122	pure
CY2022	MDBH	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.0135	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0010	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2454	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2370	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0169	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2023Q4	MDBH	Deferred Tax Assets In Startup Expenditures DeferredTaxAssetsInStartupExpenditures	15054	usd
CY2022Q4	MDBH	Deferred Tax Assets In Startup Expenditures DeferredTaxAssetsInStartupExpenditures	306187	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1099590	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	82509	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	7427	usd
CY2023Q4	MDBH	Deferred Tax Assets Stock Compensation DeferredTaxAssetsStockCompensation	1062471	usd
CY2022Q4	MDBH	Deferred Tax Assets Stock Compensation DeferredTaxAssetsStockCompensation	55537	usd
CY2023Q4	MDBH	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	619900	usd
CY2022Q4	MDBH	Deferred Tax Assets Intercompany Warrants DeferredTaxAssetsIntercompanyWarrants	89769	usd
CY2023Q4	MDBH	Deferred Tax Assets Warrants DeferredTaxAssetsWarrants	67366	usd
CY2023Q4	MDBH	Deferred Tax Assets Bonus Expense DeferredTaxAssetsBonusExpense	201026	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	1158	usd
CY2023Q4	MDBH	Deferred Tax Assets Impairment Expense DeferredTaxAssetsImpairmentExpense	10500	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1828404	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1560414	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4270	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3938152	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2106113	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	967316	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	89083	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	598370	usd
CY2023Q4	MDBH	Deferred Tax Liabilities Investment Securities DeferredTaxLiabilitiesInvestmentSecurities	279863	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	967316	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	967316	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	967316	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3938152	usd

Files In Submission

Name	View Source	Status
0001493152-24-012008-index-headers.html	Edgar Link	pending
0001493152-24-012008-index.html	Edgar Link	pending
0001493152-24-012008.txt	Edgar Link	pending
0001493152-24-012008-xbrl.zip	Edgar Link	pending
ex19-1.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-3.htm	Edgar Link	pending
ex99-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
mdbh-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mdbh-20231231_cal.xml	Edgar Link	unprocessable
mdbh-20231231_def.xml	Edgar Link	unprocessable
mdbh-20231231_lab.xml	Edgar Link	unprocessable
mdbh-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDBH
MDB Capital Holdings LLC Stock $mdbh

2023 Q4 Form 10-K Financial Statement

#000149315224012008 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH MDB Capital Holdings LLC Stock $mdbh

2023 Q4 Form 10-K Financial Statement

#000149315224012008 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH
MDB Capital Holdings LLC Stock $mdbh